Toxoplasma Gondii Igg Igm Tri Lines Rapid Test Suppliers and Manufacturers

Uncut Sheet Toxoplasma Gondii IgG/IgM Tri-Lines Rapid Test Specimen :Whold Blood/Serum/Plasma INTENDED USE The One Step TOXO IgG/IgM Test is a rapid chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to Toxoplasma gondii in Whole Blood /Serum / Plasma to aid in the diagnosis of TOXO infection. Toxoplasma gondii is an obligate intracellular protozoan parasite with a worldwide distribution. Serological data indicates that approximately 30% of the population of most industrialized nations is chronically infected with the organism. A variety of serologic tests for antibodies to Toxoplasma gondii have been used as an aid in diagnosis of acute infection and to assess previous exposure to the organism. These tests are the Sabin-Feldman dye test, direct agglutination, indirect hemagglutination, latex agglutination, indirect immunofluorescence, and ELISA. Recently, lateral flow chromatographic immunoassay, such as The Toxo IgM/IgG Rapid Test (Whole Blood/Serum/Plasma) was introduced into the clinic for the serodiagnosis of Toxoplasma gondii infection. One step TOXO IgG/IgM Test is a simple, visual qualitative test that detects TOXO antibodies in human Whole Blood/serum/plasma. The test is based on immunochromatography and can give a result within 15 minutes. Storage and Stability Store as packaged in the sealed pouch at room temperature or refrigerated (4-30â?? or 40-86â??). The test device is stable through the expiration date printed on the sealed pouch. The test must remain in the sealed pouch until use.

Covid-19 IgG/IgM Antibody test kit, 10 minute results 98% accuracy IgG, 96% IgM. Zero cross reactivity with Influenza A&B, Chlamydia, HIV, Hepatitis, EB, Measles, Mumps. Independently verified.

VETLabs Toxoplasma IgM/IgG test is a sandwich lateral flow immunochromatographic assay, developed and manufactured by Bioguard Corporation, for the rapid and qualitative detection of Toxoplasma IgM/IgG in cat's blood. The test device has a testing window, coated by an invisible T (test) zone and C (control) zone. When a sample is applied to the sample well on the device, the reagent will laterally flow on the surface of the test strip. If there is enough Toxoplasma IgM/IgG in the sample, a visible T band will appear. The C band should always appear after a sample is applied, indicating a valid test. By the means, the device can accurately indicate the presence of Toxoplasma IgM/IgG in the specimen. Kit components: 5 test per box and/or 10 test kit per box in an individual foil pouch with a desiccant and disposable dropper, EDTA blood collection tube, Assay buffer bottle, Instruction manual

The Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi (S. typhi)G and IgM in human serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi. Any reactive specimen with the Typhoid IgG/IgM 2.0 Rapid Test must be confirmed with alternative testing method(s).

The Cytomegalovirus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of Cytomegalovirus (CMV) in human serum/plasma samples. Cytomegalovirus is a herpes virus and a leading biological factor causing congenital abnormalities and complications among those who receive massive blood transfusions and immunosuppressive therapy. About half of the number of pregnant women who contract a primary infection, spread the disease to their fetus. When acquired in-utero, the infection may cause mental retardation, blindness, and/or deafness. Serological tests for detecting the presence of antibody to CMV can provide valuable information regarding the history of previous infection, diagnosis or active or recent infection, as well as in screening blood for transfusions in newborns and immuno-compromised recipients. The Cytomegalovirus Rapid Test Device (Serum/Plasma) has been designed to detect CMV through visual interpretation of color development in the internal strip. The membrane was immobilized with antigens of CMV on the test region. During the test, the specimen is allowed to react with colored recombinant mouse anti-human IgM latex conjugates, which were precoated on the sample pad of the test. The mixture then moves on the membrane by a capillary action, and interact with reagents on the membrane. If there were enough CMV antibodies in specimens, a colored band will from at the test region of the membrane. Presence of this colored band indicates a positive result, while its absence indicates a negative result. Appearance of a colored band at the control region serves as a procedural control. This indicates that proper volume of specimen has been added and membrane wicking has occurred.

INTENDED USE THE ONE STEP ANTI-DENGUE (IGM & IGG) TRI-LINE TEST IS A COLLOIDAL GOLD ENHANCED, RAPID IMMUNOCHROMATOGRAPHIC ASSAY FOR THE QUALITATIVE DETECTION OF ANTIBODIES (IGM & IGG) TO DENGUE VIRUS (DV) IN HUMAN WHOLE BLOOD, SERUM OR PLASMA. THIS TEST IS A SCREENING TEST, AND ALL POSITIVES MUST BE CONFIRMED USING AN ALTERNATE TEST SUCH AS WESTERN BLOT. THE TEST IS INTENDED FOR HEALTHCARE PROFESSIONAL USE ONLY. 25PCS/BOX

Specification Strength/ Size Packing Size Packed In Filariasis Kit Includes One test Strip, Desiccant and Dropper 50 Strip Test Per Pack 50 Box Pack

General Information One-Step Chikungunya IgG/IgM Rapid Test is detection of IgG and IgM anti-chikungunya virus CHIK in human blood. Sensitivity: 90.3% , Specificity: 100% Specimen : Serum, Plasma or Whole Blood Reading Time : 10 min

General Information One-Step Leishmania IgG/IgM Rapid Test is detection antibodies IgG and IgM to the subspecies of the Leishmania donovani (L. donovani), the Visceral leishmaniasis causative protozoans in human blood. Sensitivity: 91.2 % , Specificity: 99.5% Specimen : Serum, Plasma or Whole Blood Reading Time : 10 min

Uncut Sheet Strep A IgG/IgM Rapid Test Format:Cassette/Strip Uncut Sheet A rapid test for the qualitative detection of Strep A antigen in throat swab specimens.For professional in vitro diagnostic use only. INTENDED USE The Strep A Rapid Test Strip (Throat Swab) is a rapid chromatographic immunoassay for the qualitative detection of Strep A antigen from throat swab specimens to aid in the diagnosis of Group A Streptococcal infection. SUMMARY Streptococcus pyogenes is non-motile gram-positive cocci, which contains the Lancefield group A antigen that can cause serious infections such as pharyngitis, respiratory infection, impetigo, endocarditis, meningitis, puerperal sepsis, and arthritis.1 Left untreated, these infections can lead to serious complications, including rheumatic fever and peritonsillar abscess.2 Traditional identification procedures for Group A Streptococci infection involve the isolation and identification of viable organisms using techniques that require 24 to 48 hours or longer.3,4 The Strep A Rapid Test Strip (Throat Swab) is a rapid test to qualitatively detect the presence of Strep A antigen in throat swab specimens, providing results within 5 minutes. The test utilizes antibodies specific for whole cell Lancefield Group A Streptococcus to selectively detect Strep A antigen in a throat swab specimen. PRINCIPLE The Strep A Rapid Test Strip (Throat Swab) is a qualitative, lateral flow immunoassay for the detection of Strep A carbohydrate antigen in a throat swab. In this test, antibody specific to Strep A carbohydrate antigen is coated on the test line region of the test. After the test strip is immersed into a specimen, the extracted throat swab specimen reacts with an antibody to Strep A that is coated onto particles. This mixture migrates up the membrane to react with the antibody to Strep A on the membrane and generate a colored line in the test line region. The presence of this colored line in the test line region indicates a positive result, while its absence indicates a negative result. To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.

Product Details: Number of Reactions(Preps)/Kit : 10T Brand : CTK BioTech Result Time (Rapid Kits) : 15 min Sample Type : Blood Test Type : Rapid Test CAT No : AR0151C Use of conserved antigens allows pan-filaria tests to be applicable Simple procedure provides alternative to diagnosis by blood smear Use serum, plasma or whole blood No restrictions on time of day for sample collection Each kit contains: Individually sealed foil pouches containing: One cassette device One desiccant Plastic droppers Sample diluent (1 bottle, 5 mL) One package insert (instruction for use)

General Information One-Step Dengue Rapid Test is to detect IgG&IgM antibodies in serum, plasma or whole blood. For Dengue IgG/IgM Ab test: Sensitivity : 99.9% , Specificity : 99.5% Specimen : Serum , Plasma and Whole Blood Reading Time : 10 min

Monkeypox IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to monkeypox virus in human whole blood, serum or plasma. This test provides only a preliminary test result.

Our COVID-19 rapid test kit can be used effectively on many levels for proper screening and strategic preparedness toward the pandemic. The test kit requires no sophisticated equipment nor laboratory settings. Our SARS-COV-2 Antibody Rapid Test Kit can be applied for screening of COVID-19 disease on the following: General practitioners and external clinics level to detect previous SARS-COV-2 viral infections on both symptomatic and asymptomatic patients. Determination of the immunity level of front-line healthcare workers, which can help in the development of pandemic preparedness strategies at national levels. Epidemiological COVID-19 surveys at national and district levels for research purposes. Airport screening for arriving /departing passengers to control the pandemic in the aviation industry. Suspected cases exclusion to minimize cost and time spent in the RT-PCR testing procedures. Screening on the national level to facilitate decision making regarding lockdown and curfew easing strategies. Phoenix Bioscience is offering a competitive price for a high-quality kit that is made in Canada and used currently to combat the pandemic in most American cities.

Covid Ab IgG/IgM Ab Whole blood test device Sensitivity: 86.94% Specificity: 99.31% Accuracy: 93.36%

Uncut Sheet HIV 1/2 Tri-Lines Rapid Test Package:30sheets/pouch Specimen:Whole blood/Serum/plasma INTENDED USE The HIV-1/2 Rapid Screen Test (RST) is a qualitative test for the detection of antibodies to Human Immunodeficiency Virus type 1 and 2(HIV-1/2) in human serum/plasma and whole blood. It is considered as an initial screening test for HIV-1/2 antibodies. All positive specimens must be confirmed with Western Blot or other qualified EIA. PRECAUTION 1.For in vitro diagnostic uses only. 2.All patient samples should be treated as if capable of transmitting diseases. 3.Do not use test kit beyond expiration date. 4.Icteric, lipemic, hemolysed, heat treated and contaminated sera may cause erroneous results. SUMMARY AND EXPLANATION OF THE TEST It has been shown that the acquired immunodeficiency syndrome (AIDS) is caused by viruses transmitted by sexual contact, transfusion, use of contaminated blood products and sharing contaminated needles. HIV-1 and HIV-2 viruses have been isolated from patients with AIDS and AIDS-related complex (ARC), high-risk persons for AIDS. HIV-1 and HIV-2 viruses delete T helper cells, a subpopulation of T cells for body defense, thus causing AIDS patients susceptible to opportunistic infections and developing malignant tumors. The incidence of specific antibodies to HIV-1/2 is high in AIDS, ARC and persons with high risk for AIDS. The HIV-1/2 Rapid Screen Test is designed to detect antibodies to HIV-1/2 in AIDS patients, ARC or high risk persons and identify any potential donors carrying these antibodies in serum specimens. PRINCIPLE HIV-1/2 RST is a chromatographic immunoassay (CIA) for the detection of antibodies to HIV-1/2 in human serum/plasma and whole blood. HIV-1/2 specific antigens are precoated onto membrane as a capture reagent on the test region. During the test, specimen is allowed to react with the colloidal gold particles, which have been labeled with HIV-1/2 specific antigens. Antibodies to HIV-1/2, if present, a red colored band will develop on the membrane in proportion to the amount of HIV-1/2 antibodies present in the specimen. Absence of this red colored band in the test region suggests a negative result. To serve as a procedural control, red colored band in the control region will always appear regardless the presence of antibodies to HIV-1/2.

COVID-19 IgG/IgM Rapid Test Kit (Colloidal Gold) The accuracy of the rapid test is 93% for IgM detection and 98% for IgG detection, compared to the RT-PCR Tests done at individual labs in The Netherlands. Pricing clears and depends on volumes naturally. Please ask the exact quote with the volume requested information. CE and FDA EUA approved Made in USA, Germany, Canada